Article
[Pathophysiology and treatment of adult Langerhans cell histiocytosis].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2020
Tojo Arinobu, Kobayashi Masayuki
Abstract excerpt
Langerhans cell histiocytosis (LCH) is a rare disease characterized by tissue infiltration of clusters of CD1a+/CD207+ histiocyte-like cells and a resultant surrounding inflammatory reaction. Because of its morphological similarity to cutaneous Langerhans cells, LCH was formerly named histiocytosis X in 1987. However, its cell lineage appears closely related to myeloid dendritic cells. In 2010, BRAF-V600E was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
